Submission Details
| 510(k) Number | K182651 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 24, 2018 |
| Decision Date | January 16, 2019 |
| Days to Decision | 114 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K182651 is an FDA 510(k) clearance for the HbA1c Advanced, a Hemoglobin A1c Test System (Class II — Special Controls, product code PDJ), submitted by Beckman Coulter Ireland, Inc. (O'Callaghan'S Mills, IE). The FDA issued a Cleared decision on January 16, 2019, 114 days after receiving the submission on September 24, 2018. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1373.
| 510(k) Number | K182651 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 24, 2018 |
| Decision Date | January 16, 2019 |
| Days to Decision | 114 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | PDJ — Hemoglobin A1c Test System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1373 |
| Definition | Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes. |